Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis
NCT00859287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10703
Last updated 2009-07-15
Summary
This open label, non-interventional study is to compare the efficacy of Omepral® tablet and any other treatments excepting proton pump inhibitors (PPIs) for the treatment of various type of acid reflux related symptoms in patients with reflux esophagitis.
Conditions
- Reflux Esophagitis
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AstraZeneca Japan Medical Director MD · AstraZeneca
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Completion
- 2008-07-31
More Related Trials
-
A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
NCT00259051 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects
NCT05651074 ·Status: UNKNOWN ·Phase: PHASE1
-
Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis
NCT00586963 ·Status: COMPLETED
-
Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis
NCT03086070 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Relative Bioavailability of Two AG-881 Formulations and Evaluate the Effect of Food and Omeprazole on the Pharmacokinetics of AG-881
NCT04128787 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects
NCT01136317 ·Status: COMPLETED ·Phase: PHASE2
-
Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage
NCT00524329 ·Status: COMPLETED
-
A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis
NCT05604261 ·Status: UNKNOWN ·Phase: PHASE2
-
Sopran - Omeprazole Treatment Versus Surgery
NCT00256737 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.
NCT00206284 ·Status: COMPLETED ·Phase: PHASE2
-
To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
NCT01249651 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal
NCT07142486 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone
NCT04130659 ·Status: RECRUITING ·Phase: NA
-
Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding
NCT03980496 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer
NCT00401752 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.
NCT07010107 ·Status: RECRUITING ·Phase: PHASE3
-
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
NCT01093755 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic Study Comparing the Effects of Two Different Forms of Omeprazole (P07812) (COMPLETED)
NCT01077076 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment
NCT02708355 ·Status: COMPLETED ·Phase: PHASE4
-
To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin
NCT00442052 ·Status: COMPLETED ·Phase: PHASE1
-
Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)
NCT01669811 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed
NCT00644735 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
NCT00352261 ·Status: COMPLETED ·Phase: PHASE4
-
APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation
NCT00546065 ·Status: TERMINATED ·Phase: NA
-
Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)
NCT01587885 ·Status: COMPLETED ·Phase: PHASE4